|
Index of reports
> Cases resulting in life threatening events (42)
> Cases with Blood Lactate Dehydrogenase Increased (12)
Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in life threatening events where reactions include blood lactate dehydrogenase increased.
Adverse event in 59 year old female receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-10-16
Patient: 59 year old female
Adverse reactions / side effects: Skin Exfoliation, Necrosis, Blood Albumin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Blister, Lymphocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Blood Cholinesterase Decreased, Protein Total Decreased, Haemoglobin Decreased, Rash Erythematous, Skin Erosion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresolin
Dosage: 50 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-30
End date: 2007-08-08
Baktar
Dosage: 2 g/day
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2007-07-24
End date: 2007-08-01
Dormicum
Dosage: 10 ug/day
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Lansoprazole
Dosage: 60 mg/day
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Lansoprazole
Dosage: 30 mg/day
Administration route: Oral
Start date: 2007-08-04
End date: 2007-08-21
Levofloxacin
Dosage: 400 mg/day
Administration route: Oral
Indication: Infection
Start date: 2007-08-08
End date: 2007-08-12
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Olmetec
Dosage: unk, unk
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-21
Omegacin
Dosage: 600 mg/day
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Pentazocine Lactate
Dosage: 30 ug/day
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Prodif
Dosage: 800 mg/day
Start date: 2007-07-23
End date: 2007-08-04
Prodif
Dosage: 400 mg/day
Start date: 2007-07-23
End date: 2007-08-04
Voltaren
Dosage: 25 mg/day
Indication: Antipyresis
Start date: 2007-07-23
End date: 2007-08-05
Other drugs received by patient: Polymyxin B; Elaspol
Adverse event in 75 year old female receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-16
Patient: 75 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Hypoventilation, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Anaphylactic Shock, Hypoaesthesia, Hypoxic Encephalopathy, Heart Rate Decreased, Gamma-Glutamyltransferase Increased, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Nuclear Magnetic Resonance Imaging Abnormal, Blood Sodium Increased, Blood Pressure Immeasurable, Altered State of Consciousness
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-16
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Dyspnoea, Neutrophil Count Increased, Monocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-29
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Monocyte Count Decreased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-19
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Oxygen Saturation Decreased, Lymphocyte Count Decreased, White Blood Cell Count Increased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Monocyte Count Decreased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-07
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Petechiae, Pyrexia, Erythema, Blood Fibrinogen Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Cough, Renal Failure Acute, Hypertensive Encephalopathy, Dyspnoea, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Life Support, Rash, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium; Methylprednisolone 16mg TAB
Adverse event in 11 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-04
Patient: 11 year old male, weighing 32.0 kg (70.4 pounds)
Adverse reactions / side effects: Blood PH Increased, Disseminated Intravascular Coagulation, Petechiae, Blood Albumin Decreased, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Cough, Dyspnoea, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Pancytopenia, Protein Total Decreased, Lymphocyte Stimulation Test Positive, Rash, Aspartate Aminotransferase Increased, Platelet Count Decreased, PO2 Increased, Lung Infiltration, Calculus Ureteric
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Predonine; Bufferin; Sulpyrine; Kashilon; Cefazolin Sodium
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-05-11
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-04-06
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-03-16
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 75 year old female receiving Voltaren (Diclofenac)
Reported by a pharmacist from Japan on 2007-01-17
Patient: 75 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Hypoventilation, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Anaphylactic Shock, Hypoaesthesia, Hypoxic Encephalopathy, Heart Rate Decreased, Blood Potassium Decreased, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Nuclear Magnetic Resonance Imaging Abnormal, Blood Sodium Increased, Depressed Level of Consciousness, Blood Pressure Immeasurable
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 75 year old female receiving Voltaren (Diclofenac)
Reported by a pharmacist from Japan on 2007-01-16
Patient: 75 year old female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Hypoventilation, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Anaphylactic Shock, Hypoaesthesia, Hypoxic Encephalopathy, Heart Rate Decreased, Blood Potassium Decreased, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Nuclear Magnetic Resonance Imaging Abnormal, Blood Sodium Increased, Depressed Level of Consciousness, Blood Pressure Immeasurable
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren (Diclofenac)
|
